glycyl-arginyl-glycyl-aspartyl-seryl-proline and Acute Confusional Senile Dementia

glycyl-arginyl-glycyl-aspartyl-seryl-proline has been researched along with Acute Confusional Senile Dementia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bi, X; Gall, CM; Lynch, G; Zhou, J	1

Other Studies

1 other study(ies) available for glycyl-arginyl-glycyl-aspartyl-seryl-proline and Acute Confusional Senile Dementia

Article	Year
Uptake and pathogenic effects of amyloid beta peptide 1-42 are enhanced by integrin antagonists and blocked by NMDA receptor antagonists. Neuroscience, 2002, Volume: 112, Issue:4 Topics: 2-Amino-5-phosphonovalerate; Alzheimer Disease; Amyloid beta-Peptides; Animals; Cathepsin D; Culture Techniques; Hippocampus; Immunohistochemistry; Integrins; Microglia; Oligopeptides; Peptide Fragments; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate	2002

Article

Year

Uptake and pathogenic effects of amyloid beta peptide 1-42 are enhanced by integrin antagonists and blocked by NMDA receptor antagonists.

Neuroscience, 2002, Volume: 112, Issue:4

Topics: 2-Amino-5-phosphonovalerate; Alzheimer Disease; Amyloid beta-Peptides; Animals; Cathepsin D; Culture Techniques; Hippocampus; Immunohistochemistry; Integrins; Microglia; Oligopeptides; Peptide Fragments; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate

2002